The pharmaceutical and the consumer durables sectors, which depend on China for imports, have not been impacted yet due to unrest in China with people protesting against lockdowns.
But the lockdown could have an impact on the supply of components used in consumer durables if it continues for the next fortnight.
In the pharmaceutical industry, Indian players import 66-70 per cent of their bulk drug requirements from China. So far, there have been no supply deficiencies, but firms are keeping a close watch on the situation, and say that pricing volatility continues.
Sudarshan Jain, secretary general of the Indian Pharmaceutical